company background image
VIMAB logo

Vimab Group OM:VIMAB Stock Report

Last Price

SEK 7.40

Market Cap

SEK 194.5m

7D

-8.0%

1Y

-22.1%

Updated

15 Jun, 2025

Data

Company Financials

Vimab Group (VIMAB) Stock Overview

Vimab Group AB (publ) is involved in management consulting activities in the areas of energy services, and industrial and environmental technology in Sweden and internationally. More details

VIMAB fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health2/6
Dividends0/6

VIMAB Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

Vimab Group AB (publ) Competitors

Price History & Performance

Summary of share price highs, lows and changes for Vimab Group
Historical stock prices
Current Share PriceSEK 7.40
52 Week HighSEK 23.60
52 Week LowSEK 6.50
Beta-0.75
1 Month Change-5.37%
3 Month Change-15.91%
1 Year Change-22.11%
3 Year Changen/a
5 Year Changen/a
Change since IPO-26.00%

Recent News & Updates

Take Care Before Jumping Onto Vimab Group AB (publ) (STO:VIMAB) Even Though It's 26% Cheaper

Feb 16
Take Care Before Jumping Onto Vimab Group AB (publ) (STO:VIMAB) Even Though It's 26% Cheaper

Recent updates

Take Care Before Jumping Onto Vimab Group AB (publ) (STO:VIMAB) Even Though It's 26% Cheaper

Feb 16
Take Care Before Jumping Onto Vimab Group AB (publ) (STO:VIMAB) Even Though It's 26% Cheaper

Vimab Group AB (publ) (STO:VIMAB) Soars 29% But It's A Story Of Risk Vs Reward

Dec 22
Vimab Group AB (publ) (STO:VIMAB) Soars 29% But It's A Story Of Risk Vs Reward

Vimab Group AB (publ)'s (STO:VIMAB) Shares Not Telling The Full Story

Nov 06
Vimab Group AB (publ)'s (STO:VIMAB) Shares Not Telling The Full Story

We Think Vimab Group (STO:VIMAB) Is Taking Some Risk With Its Debt

Mar 14
We Think Vimab Group (STO:VIMAB) Is Taking Some Risk With Its Debt

Shareholder Returns

VIMABSE Professional ServicesSE Market
7D-8.0%-2.8%-2.9%
1Y-22.1%-11.3%-4.2%

Return vs Industry: VIMAB underperformed the Swedish Professional Services industry which returned -11.3% over the past year.

Return vs Market: VIMAB underperformed the Swedish Market which returned -4.2% over the past year.

Price Volatility

Is VIMAB's price volatile compared to industry and market?
VIMAB volatility
VIMAB Average Weekly Movement8.0%
Professional Services Industry Average Movement6.6%
Market Average Movement6.8%
10% most volatile stocks in SE Market13.2%
10% least volatile stocks in SE Market4.1%

Stable Share Price: VIMAB has not had significant price volatility in the past 3 months compared to the Swedish market.

Volatility Over Time: VIMAB's weekly volatility has decreased from 20% to 8% over the past year.

About the Company

FoundedEmployeesCEOWebsite
2011199Peter Fredellvimabgroup.com

Vimab Group AB (publ) is involved in management consulting activities in the areas of energy services, and industrial and environmental technology in Sweden and internationally. The company was incorporated in 2011 and is based in Stockholm, Sweden.

Vimab Group AB (publ) Fundamentals Summary

How do Vimab Group's earnings and revenue compare to its market cap?
VIMAB fundamental statistics
Market capSEK 194.46m
Earnings (TTM)-SEK 89.86m
Revenue (TTM)SEK 313.40m
0.6x
P/S Ratio
-2.2x
P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
VIMAB income statement (TTM)
RevenueSEK 313.40m
Cost of RevenueSEK 246.68m
Gross ProfitSEK 66.72m
Other ExpensesSEK 156.58m
Earnings-SEK 89.86m

Last Reported Earnings

Mar 31, 2025

Next Earnings Date

n/a

Earnings per share (EPS)-3.42
Gross Margin21.29%
Net Profit Margin-28.67%
Debt/Equity Ratio1,563.4%

How did VIMAB perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/06/15 03:56
End of Day Share Price 2025/06/13 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Vimab Group AB (publ) is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.